Development of JCARH125 optimization of a fully human anti-Bcma CAR for use in the treatment of multiple myeloma

Autor: Harrington, Kim, Wu, Rebecca, Hauskins, Collin, Amin, Rupesh, Long, Thomas, Chen, Aye, Rahardjo, Ayu, Thayer, Casey, Navvaro, Garnet, Myers, Madelyn, Jones, Jon, Baturevych, Alex, Morkowski, Stan, Salmon, Ruth, Bond, Christopher J., Stæhr, Mette, Purdon, Terence J., Masakayan, Reed, Liu, Cheng, Liu, Hong, Xu, Yiang, Wang, Pei, Pont, Margot, Green, Damian J., Brentjens, Reiner J., Smith, Eric L., Sather, Blythe Duke
Jazyk: angličtina
Rok vydání: 2017
Zdroj: Harrington, K, Wu, R, Hauskins, C, Amin, R, Long, T, Chen, A, Rahardjo, A, Thayer, C, Navvaro, G, Myers, M, Jones, J, Baturevych, A, Morkowski, S, Salmon, R, Bond, C J, Stæhr, M, Purdon, T J, Masakayan, R, Liu, C, Liu, H, Xu, Y, Wang, P, Pont, M, Green, D J, Brentjens, R J, Smith, E L & Sather, B D 2017, ' Development of JCARH125 optimization of a fully human anti-Bcma CAR for use in the treatment of multiple myeloma ', Blood, vol. 130, no. Suppl. 1, 1813 . https://doi.org/10.1182/blood.V130.Suppl_1.1813.1813
Databáze: OpenAIRE